Phase 1 Bioavailability Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Curcumin and Retinal Study

SafetyGut MicrobiomeBioavailability

Texas Tech University Health Sciences Center60 enrolled1 locationNCT05774704

Completed

Phase 1

Comparative assessment of the absorption of a generic formulation of tiotropium test product 1 and tiotropium test product 2 against the innovator Spiriva HandiHaler conducted under fasting conditions in healthy male and female volunteers

Bioavailability study conducted in healthy volunteers comparing three formulations of tiotropium with no health condition or problem studied. Tiotropium is a long-acting, antimuscarinic agent, which is often referred to as an anticholinergic and is used to make breathing easier for people with Chronic Obstructive Pulmonary Disease (COPD).

Zenith Technology Corp Ltd24 enrolled1 locationACTRN12615000073505

Suspended

Phase 1

Bioavailability of orally administered gamma-glutamylcysteine

This bioavailability trial represents an initial investigation in healthy volunteers to determine the potential of gamma-glutamylcysteine (GGC) to augment cellular glutathione levels. Glutathione depletion is associated with numerous age related disorders.

University of New South Wales18 enrolled1 locationACTRN12612000952842